Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126801803 | 12680180 | 3 | F | 20160509 | 20160912 | 20160824 | 20160922 | EXP | IT-MINISAL02-370916 | IT-TEVA-684883ACC | TEVA | 58.66 | YR | F | Y | 0.00000 | 20160922 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126801803 | 12680180 | 1 | PS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | TOTAL | Y | U | 74342 | TABLET | |||||||
| 126801803 | 12680180 | 2 | SS | TRIAZOLAM. | TRIAZOLAM | 1 | Oral | TOTAL | Y | U | 74445 | TABLET | |||||||
| 126801803 | 12680180 | 3 | SS | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | Oral | TOTAL | Y | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126801803 | 12680180 | 1 | Drug abuse |
| 126801803 | 12680180 | 2 | Drug abuse |
| 126801803 | 12680180 | 3 | Drug abuse |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126801803 | 12680180 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126801803 | 12680180 | Coma | |
| 126801803 | 12680180 | Drug abuse | |
| 126801803 | 12680180 | Loss of consciousness | |
| 126801803 | 12680180 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |